Skip to main content
Premium Trial:

Request an Annual Quote

Avesthagen to Use Affymetrix Microarrays in Parsi Study

NEW YORK (GenomeWeb News) – Affymetrix said today that Avesthagen will use its microarrays in a genetic study of the Parsi-Zoroastrian population.
 
Bangalore, India-based Avesthagen plans to conduct a study, called the AvestaGenome Project, of more than 60,000 Parsi individuals in an effort to reveal the genetic basis of longevity among that population. According to the companies, 31 percent of the Parsi population lives beyond the age of 60 compared to 7 percent nationally in India.
 
Avesthagen researchers intend to correlate genes with longevity, as well as neurodegenerative conditions, breast cancer, diabetes, and other complex diseases in the Parsi community.
 
The genotyping phase of the project began in October 2007. By the middle of this year, Avesthagen plans to perform gene expression profiling and transcript mapping experiments across a subset of samples. The project is scheduled to finish by 2013.
 
Financial terms of the agreement were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.